(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202606 | 202506 | % Var | 202606 | 202506 | % Var | 202603 | 202503 | % Var | |
| Sales | 12866.40 | 10388.35 | 23.85 | 12866.40 | 10388.35 | 23.85 | 45520.92 | 41161.49 | 10.59 |
| Other Income | 588.21 | 547.41 | 7.45 | 588.21 | 547.41 | 7.45 | 3038.97 | 2150.75 | 41.30 |
| PBIDT | 5323.34 | 4135.86 | 28.71 | 5323.34 | 4135.86 | 28.71 | 19669.73 | 16576.93 | 18.66 |
| Interest | 6.91 | 74.35 | -90.71 | 6.91 | 74.35 | -90.71 | 180.73 | 228.37 | -20.86 |
| PBDT | 5316.43 | 4061.51 | 30.90 | 5316.43 | 4061.51 | 30.90 | 19245.54 | 16348.56 | 17.72 |
| Depreciation | 439.53 | 437.68 | 0.42 | 439.53 | 437.68 | 0.42 | 1762.43 | 1692.71 | 4.12 |
| PBT | 4876.90 | 3623.83 | 34.58 | 4876.90 | 3623.83 | 34.58 | 17483.11 | 14655.85 | 19.29 |
| TAX | 1232.99 | 931.25 | 32.40 | 1232.99 | 931.25 | 32.40 | 4487.60 | 3758.32 | 19.40 |
| Deferred Tax | -18.93 | -1.46 | 1196.58 | -18.93 | -1.46 | 1196.58 | -38.29 | 91.24 | -141.97 |
| PAT | 3643.91 | 2692.58 | 35.33 | 3643.91 | 2692.58 | 35.33 | 12995.51 | 10897.53 | 19.25 |
| Equity | 164.96 | 164.76 | 0.12 | 164.96 | 164.76 | 0.12 | 164.76 | 164.76 | 0.00 |
| PBIDTM(%) | 41.37 | 39.81 | 3.92 | 41.37 | 39.81 | 3.92 | 43.21 | 40.27 | 7.29 |
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1931.85 |
| Dr. Reddys Labs. | 1197.45 |
| Cipla | 1462.10 |
| Lupin | 2262.40 |
| Zydus Lifesciences | 1151.95 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: